Real-time enrollment status for this accelerated phase myeloproliferative neoplasm clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:01 PM UTC
| NCT Number | NCT07148947 |
| Recruiting Status | Recruiting |
| Condition | Accelerated Phase Myeloproliferative Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Washington |
| Last Updated on CT.gov | March 4, 2026 (Mar 4, 2026) |
As of July 17, 2026: Clinical trial NCT07148947 is currently recruiting participants. This phase2 study for accelerated phase myeloproliferative neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Washington. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07148947 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07148947 was last updated Mar 4, 2026 (March 4, 2026). HelloStudys verifies this status automatically.